Skip to content
Independent Medical Alliance
  • Twitter
  • Rumble
  • Instagram
  • Connect with Us
Donate
  • My Accountmy account
  • Home
    Latest Updates

    Stay up-to-date with the latest news from our fast-moving field.

    View
    Blog

    Subscribe to our blog to read our weekly news capsule and be the first to receive the latest announcements from IMA.

    Read Now
    In the News

    Read media coverage of IMA from around the world.

    View
  • TREATMENT
    Treatment Guidelines

    Strategies to prevent and treat COVID-19, Long COVID, RSV, Flu and Vaccine-related issues:

    • Prevention
    • Treatment
    • Long COVID Recovery
    • Vaccine Injury Prevention
    • Shedding from Vaccines
    • Long Vax Recovery

    Strategies to prevent and treat conditions like cancer, depression, insulin resistance and more:

    • Brain Health
    • Cancer Care
    • Depression & Mental Health
    • Fasting & Healthy Eating
    • Insulin Resistance
    • Sepsis
  • Resources
    Wondering where to begin?

    Let us help you find what you’re looking for. We know COVID-19 can be overwhelming; click below to learn more about the resources available to you on this website.

    get started
    Patient Resources
    • Find a Provider
    • Find a Pharmacy
    • Tools & Guides
    • Testimonials
    • FAQ
    Professional Resources
    • Journal of Independent Medicine

    • Research
    • Ivermectin Facts
    • Informed Consent
    • Join the Alliance
  • Education
    About the education portal

    IMA’s goal is to educate healthcare providers and empower patients with the tools and resources they need to take control of their own health.

    Education on Demand

    Stream video lectures, download slide presentations, and get exclusive access to key facts, data, and references from IMA (formerly FLCCC) educational programs.

    • My Content
    • Explore Courses
  • Community
    Events

    IMA hosts dynamic events that unite top experts from diverse fields for learning, sharing, and collaboration. Join us for unique in-person and virtual experiences that foster knowledge exchange and meaningful partnerships.

    • Weekly Webinar

    • Annual Conference
    Forums

    Join the discussion! IMA public and private forums are a place for the IMA community to connect without fear of censorship.

    • Forums
    Membership

    Explore IMA (formerly FLCCC) membership options for healthcare professionals and committed individuals who share a common passion and purpose. Members receive access to private forums and exclusive content and events while supporting IMA’s mission.

    • Join Now
    • Sign In
  • About
    About the IMA

    Learn about the history of IMA (formerly FLCCC), our mission and vision, and how you can get involved.

    learn more
    • Founders & Clinical Team
    • Senior Fellows
    • Contributors
    • Partners
    • Connect with Us
    • Advocacy
    • Impact Reports
    • Annual Reports
    • Support Us
    • Shop our Store
  • Search
    Search for:
  • IMA HOME
    • Latest UpdatesGet the latest updates from the FLCCC Alliance and their work on COVID-19 prevention and treatment.
    • Blog
    • In the NewsCheck out the latest in news coverage focused on the FLCCC Alliance and our members!
  • TREATMENT
    • Prevention
    • Treatment
    • Recovery
    • More Protocols
      • Brain Health
      • Cancer Care
      • Depression & Mental Health
      • Eat Well
      • Insulin Resistance
      • Sepsis Care
      • Shedding from Vaccines
  • RESOURCES
    • Journal of Independent Medicine
    • Research
    • Tools & Guides
    • Find a Provider
    • Find a Pharmacy
    • FAQ
    • Efficacy of Ivermectin
    • Join The Alliance
  • EDUCATION
    • Courses
  • COMMUNITY
    • Events
      • Annual Conference 2025
      • Weekly WebinarsJoin FLCCC’s live webinars every Wednesday at 7 pm ET for the latest updates on COVID news & treatment options. Hear from experts, get questions answered!
    • Forums
    • Membership
  • ABOUT
    • Founders & Clinical Team
    • Senior Fellows
    • IMA Contributors
    • Partners
    • Annual Reports
    • Impact Reports
    • Connect with Us
Independent Medical Alliance
  • MY ACCOUNT
  • MY FORUMS
  • MY COURSES
Search for:
  • Twitter
  • Rumble
  • Instagram
  • Connect with Us
Donate

References

Categories

Cancer Care (474) I-CARE Early Covid (187) I-CARE Flu and RSV (36) I-PREVENT (153) I-RECOVER Long Covid (111) I-RECOVER Post-Vaccine (320) MATH+ (288)

Tags

ACE2 protein (10) acute respiratory distress syndrome (21) Anti-inflammatory (13) Antidepressants (9) Ascorbic Acid (13) autoantibodies (10) autophagy (48) Breast Cancer (30) Cancer (69) Cancer Stem Cells (11) Chemotherapy (12) Colon Cancer (11) Corticosteroids (9) COVID-19 (330) COVID-19 Vaccines (8) Curcumin (14) Cytokines (13) Depression (12) Diabetes (14) Famotidine (14) Hydroxychloroquine (15) Hyperbaric Oxygen Therapy (9) Inflammation (15) intermittent fasting (14) ivermectin (53) long COVID (21) Macrophages (18) Mast Cells (8) Melatonin (23) Mitochondria (14) Myeloid Cells (10) Pneumonia (9) quercetin (15) resveratrol (11) SARS-CoV-2 (83) Sepsis (22) spermidine (11) Spike Protein (12) Thiamine (11) Thrombosis (9) Tinnitus (12) Tumor (41) Vitamin C (30) Vitamin D (29) Zinc (12)
  • Reference: Almitrine infusion in severe acute respiratory syndrome coronavirus-2 indued acute respiratory distress syndrome: A single-center observational study.

    Published On: February 1, 2021

    Authors: Caplan M, Goutay J, Bignon A, Jaillette E, Favory R PMID: 33093279 DOI: 10.1097/CCM.0000000000004711 Abstract Objectives: Treating acute respiratory failure in patients with coronavirus disease 2019 is challenging due to the lack of knowledge of the underlying pathophysiology. Hypoxemia may be explained in part by the loss of hypoxic pulmonary vasoconstriction. The present study [...]

    Categories: MATH+

    Tags: acute respiratory distress syndrome, SARS-CoV-2

  • Reference: Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post hospital discharge.

    Published On: January 7, 2021

    Authors: Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Okell T et al. PMID: 33490928 PMCID: PMC7808914 DOI: 10.1016/j.eclinm.2020.100683 Abstract Background: The medium-term effects of Coronavirus disease (COVID-19) on organ health, exercise capacity, cognition, quality of life and mental health are poorly understood. Methods: Fifty-eight COVID-19 patients post-hospital discharge [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: SARS-CoV-2

  • Reference: Early empirical assessment of the N501Y mutant strains of SARSCoV-2 in the United Kingdom, October to November 2020

    Published On: January 7, 2021

    Two new SARS-CoV-2 lineages with the N501Y mutation in the receptor-binding domain of the spike protein spread rapidly in the United Kingdom. We estimated that the earlier 501Y lineage without amino acid deletion Δ69/Δ70, circulating mainly between early September and mid-November, was 10% (6–13%) more transmissible than the 501N lineage, and the 501Y lineage with amino acid deletion Δ69/Δ70, circulating since late September, was 75% (70–80%) more transmissible than the 501N lineage.

    Categories:

    Tags: COVID-19, SARS-CoV-2, Spike Protein, United Kingdom, VOC-202012/01

  • Reference: A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin

    Published On: January 1, 2021

    Martin D. Hellwig a, Anabela Maia b https://doi.org/10.1016/j.ijantimicag.2020.106248 Abstract As COVID-19 (coronavirus disease 2019) continues to rapidly spread throughout the world, the incidence varies greatly among different countries. These differences raise the question whether nations with a lower incidence share any medical commonalities that could be used not only to explain that lower incidence [...]

    Categories:

    Tags: COVID-19, ivermectin, Prophylactic chemotherapy, SARS-CoV-2

  • Reference: Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)

    Published On: December 30, 2020

    The SARS-CoV-2 virus spreading across the world has led to surges of COVID-19 illness, hospitalizations, and death. The complex and multifaceted pathophysiology of life-threatening COVID-19 illness including viral mediated organ damage, cytokine storm, and thrombosis warrants early interventions to address all components of the devastating illness. In countries where therapeutic nihilism is prevalent, patients endure escalating symptoms and without early treatment can succumb to delayed in-hospital care and death.

    Categories:

    Tags: Ambulatory treatment, Anti-inflammatory, Anticoagulant, antiplatelet agent, Antiviral, corticosteroid, COVID-19, SARS-CoV-2

  • Reference: Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa

    Published On: December 22, 2020

    Continued uncontrolled transmission of the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) in many parts of the world is creating the conditions for significant virus evolution. Here, we describe a new SARS-CoV-2 lineage (501Y.V2) characterised by eight lineage-defining mutations in the spike protein, including three at important residues in the receptor-binding domain (K417N, E484K and N501Y) that may have functional significance. This lineage emerged in South Africa after the first epidemic wave in a severely affected metropolitan area, Nelson Mandela Bay, located on the coast of the Eastern Cape Province. This lineage spread rapidly, becoming within weeks the dominant lineage in the Eastern Cape and Western Cape Provinces. Whilst the full significance of the mutations is yet to be determined, the genomic data, showing the rapid displacement of other lineages, suggest that this lineage may be associated with increased transmissibility.

    Categories:

    Tags: SARS-CoV-2, South Africa

  • Reference: Possible prophylactic approach for SARS-CoV-2 infection by combination of melatonin, Vitamin C and Zinc in animals.

    Published On: December 3, 2020

    Authors: Fatima S, Zaidi SS, Alsharidah AS, Alijaser FS, Banu N PMID: 33344529 PMCID: PMC7744567 DOI: 10.3389/fvets.2020.585789 Abstract SARS-CoV-2, an epidemic, causes severe stress in both human and animals and may induce oxidative stress (OS) and increases susceptibility to infection. Domestic animals are found infected by their COVID-2 suffering owners. Chronic immobilization stress (CIS), a [...]

    Categories: MATH+

    Tags: Melatonin, SARS-CoV-2, Vitamin C, Zinc

  • Reference: Ivermectin, a drug to be considered for the prevention and treatment of SARS-CoV-2. Brief literature review.

    Published On: November 30, 2020

    Authors: Peralta EG, Fimia-Duarte R, Cardenas JW, Dominguez DV, Segura RB Abstract Covid-19 is one of the viral infections that have always accompanied us. In some years harmless, but from time to time with a higher risk potential. What is particularly unsettling for us is that transmission often occurs from a [...]

    Categories: MATH+

    Tags: COVID-19, ivermectin, SARS-CoV-2

  • Reference: Role of mitochondria, oxidative stress and the response to antioxidants in myalgic enecphalomyelitis/Chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’?

    Published On: November 21, 2020

    Authors: Wood E, Hall KH, Tate W PMID: 33251031 PMCID: PMC7680046 DOI: 10.1016/j.cdtm.2020.11.002 Abstract A significant number of SARS-CoV-2 (COVID-19) pandemic patients have developed chronic symptoms lasting weeks or months which are very similar to those described for myalgic encephalomyelitis/chronic fatigue syndrome. This study reviews the current literature and understanding of the role that mitochondria, [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: Chronic Fatigue Syndrome, Mitochondria, SARS-CoV-2

  • Reference: SARS-CoV-2 infection depends on cellular heparan sulphate and ACE2.

    Published On: November 12, 2020

    Authors: Clausen TM, Sandoval DR, Spliid CB, PiHl J, Painter CD, Thacker BE et al. PMID: 32970989 PMCID: PMC7489987 DOI: 10.1016/j.cell.2020.09.033 Abstract We show that SARS-CoV-2 spike protein interacts with both cellular heparan sulfate and angiotensin-converting enzyme 2 (ACE2) through its receptor-binding domain (RBD). Docking studies suggest a heparin/heparan sulfate-binding site adjacent to the ACE2-binding [...]

    Categories: MATH+

    Tags: ACE2 protein, SARS-CoV-2

Previous456Next
FLCCC Logo with white letters
Support Us

We are a 100% donor-supported 501(c)(3) non-profit organization. Our work would not be possible without you! Help us expand our reach and share life-saving research.

Give Now
shop
Contact Us
Mailing Address

Independent Medical Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About the IMA
  • Protocols

  • Providers

  • Testimonials

  • Latest Updates

  • Newsletter Signup

Follow Us
FLCCC Logo with white letters
Contact Us
Mailing Address

Independent Medical Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About IMA
  • Protocols
  • Providers
  • Testimonials
  • Latest Updates
  • Newsletter Signup
Support Us
Give Now
shop
Follow Us
Disclaimer

©2020–2025 All Rights Reserved Independent Medical Alliance (IMA), formerly FLCCC Alliance. The information contained or presented on this website is for educational purposes only. Information on this site is NOT intended to serve as a substitute for diagnosis, treatment, or advice from a qualified, licensed medical professional. The facts presented are offered as information only in order to empower you – our protocol is not medical advice – and in no way should anyone infer that we, even though we are physicians, or anyone appearing in any content on this website are practicing medicine, it is for educational purposes only. Any treatment protocol you undertake should be discussed with your physician or other licensed medical professional. Seek the advice of a medical professional for proper application of ANY material on this site or our program to your specific situation. NEVER stop or change your medications without consulting your physician. If you are having an emergency contact your emergency services: in the USA that’s 911. IMA does not use SMS to conduct marketing campaigns, however, we are required to provide the following disclaimer: By providing my phone number to “IMA”, I agree and acknowledge that “IMA” may send text messages to my wireless phone number for any purpose. Message and data rates may apply. Message frequency will vary, and you will be able to Opt-out by replying “STOP”. For information on data handling, terms of use, and disclaimers, visit our Privacy Policy & Terms.

© Copyright 2025. Independent Medical Alliance (IMA), formerly FLCCC Alliance.

Page load link
We use cookies on this site to enhance your user experience. By clicking the Accept button, you agree to us doing so. Read our Privacy Policy ACCEPT

Ask Our Experts

Have a question you don’t see on our list? Complete the form below with a question or topic you’d like our experts to consider adding to our FAQs resource center. Questions will not be answered individually (we cannot provide medical advice or treatment through this form).

Please enable JavaScript in your browser to complete this form.
Opt In
Loading

Disclaimer: We are unable to offer individualized medical advice, diagnoses, or treatment recommendations. For any personal medical decisions, always consult with your own healthcare provider.

Go to Top